BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6359846)

  • 1. Acute and long-term hemodynamic effects of oral pirbuterol in patients with chronic severe congestive heart failure: randomized double-blind trial.
    Pamelia FX; Gheorghiade M; Beller GA; Bishop HL; Olukotun AY; Taylor CR; Watson DD; Grunwald AM; Sirowatka J; Carabello BA
    Am Heart J; 1983 Dec; 106(6):1369-76. PubMed ID: 6359846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of six months of daily treatment with the beta-2 agonist oral pirbuterol on pulmonary hemodynamics in patients with chronic hypoxic cor pulmonale receiving long-term oxygen therapy.
    Biernacki W; Prince K; Whyte K; MacNee W; Flenley DC
    Am Rev Respir Dis; 1989 Feb; 139(2):492-7. PubMed ID: 2563321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The acute hemodynamic response to pirbuterol at rest and exercise in patients with heart failure with observations on long-term response.
    Uretsky BF; Seecof RM; Reddy PS
    Can J Cardiol; 1986; 2(2):80-5. PubMed ID: 3085906
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Acute effects of oral pirbuterol on myocardial oxygen metabolism and systemic hemodynamics in chronic congestive heart failure.
    Rude RE; Turi Z; Brown EJ; Lorell BH; Colucci WS; Mudge GH; Taylor CR; Grossman W
    Circulation; 1981 Jul; 64(1):139-45. PubMed ID: 7237712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hemodynamic effects of oral pirbuterol in chronic severe congestive heart failure.
    Awan NA; Evenson MK; Needham KE; Evans TO; Hermanovich J; Taylor CR; Amsterdam E; Mason DT
    Circulation; 1981 Jan; 63(1):96-101. PubMed ID: 7438412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pirbuterol: a new oral sympathomimetic amine for the treatment of congestive heart failure.
    Sharma B; Hoback J; Francis GS; Hodges M; Asinger RW; Cohn JN; Taylor CR
    Am Heart J; 1981 Sep; 102(3 Pt 2):533-41. PubMed ID: 6115572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Decreased lymphocyte beta-adrenergic-receptor density in patients with heart failure and tolerance to the beta-adrenergic agonist pirbuterol.
    Colucci WS; Alexander RW; Williams GH; Rude RE; Holman BL; Konstam MA; Wynne J; Mudge GH; Braunwald E
    N Engl J Med; 1981 Jul; 305(4):185-90. PubMed ID: 6113543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pirbuterol hydrochloride: evaluation of beta adrenergic agonist activity in reversible obstructive pulmonary disease and congestive heart failure.
    Weber RW; Nelson HS
    Pharmacotherapy; 1984; 4(1):1-10. PubMed ID: 6142449
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of chronic heart failure with pirbuterol: acute haemodynamic responses.
    Dawson JR; Canepa-Anson R; Kuan P; Whitaker NH; Carnie J; Warnes C; Reuben SR; Poole-Wilson PA; Sutton GC
    Br Med J (Clin Res Ed); 1981 May; 282(6274):1423-6. PubMed ID: 6112039
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acute and chronic effects of pirbuterol on left ventricular ejection fraction and clinical status in severe congestive heart failure.
    Colucci WS; Alexander RW; Mudge GH; Rude RE; Holman BL; Wynne J; Grossman W; Braunwald E
    Am Heart J; 1981 Sep; 102(3 Pt 2):564-8. PubMed ID: 6115573
    [No Abstract]   [Full Text] [Related]  

  • 11. Placebo-controlled study of oral enoximone in congestive heart failure with initial and final intravenous hemodynamic evaluation.
    Khalife K; Zannad F; Brunotte F; Belhadj K; Juilliere Y; Iannascoli F; Gilgenkrantz JM
    Am J Cardiol; 1987 Aug; 60(5):75C-79C. PubMed ID: 2956874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pirbuterol versus orciprenaline aerosols in the treatment of bronchial asthma.
    Beumer HM
    Int J Clin Pharmacol Ther Toxicol; 1983 Mar; 21(3):147-66. PubMed ID: 6343262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term beta-blocker vasodilator therapy improves cardiac function in idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo.
    Gilbert EM; Anderson JL; Deitchman D; Yanowitz FG; O'Connell JB; Renlund DG; Bartholomew M; Mealey PC; Larrabee P; Bristow MR
    Am J Med; 1990 Mar; 88(3):223-9. PubMed ID: 1968710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of prazosin in the management of chronic congestive heart failure: a 6-month randomized, double-blind, placebo-controlled study.
    Markham RV; Corbett JR; Gilmore A; Pettinger WA; Firth BG
    Am J Cardiol; 1983 May; 51(8):1346-52. PubMed ID: 6342353
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pirbuterol, an oral beta-adrenergic receptor agonist, in the treatment of chronic cardiac failure.
    Weber KT; Andrews V; Janicki JS; Likoff M; Reichek N
    Circulation; 1982 Dec; 66(6):1262-7. PubMed ID: 6128086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial.
    Massie B; Bourassa M; DiBianco R; Hess M; Konstam M; Likoff M; Packer M
    Circulation; 1985 May; 71(5):963-71. PubMed ID: 3886191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta-adrenergic stimulation of the failing ventricle: a double-blind, randomized trial of sustained oral therapy with prenalterol.
    Roubin GS; Choong CY; Devenish-Meares S; Sadick NN; Fletcher PJ; Kelly DT; Harris PJ
    Circulation; 1984 May; 69(5):955-62. PubMed ID: 6142775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of amiodarone on clinical status and left ventricular function in patients with congestive heart failure. CHF-STAT Investigators.
    Massie BM; Fisher SG; Radford M; Deedwania PC; Singh BN; Fletcher RD; Singh SN
    Circulation; 1996 Jun; 93(12):2128-34. PubMed ID: 8925581
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences between acute and long-term metabolic and endocrine effects of oral beta-adrenoceptor agonist therapy with pirbuterol for cardiac failure.
    Canepa-Anson R; Dawson JR; Kuan P; Poole-Wilson PA; Sutton GC; Cockrill B; Reuben SR
    Br J Clin Pharmacol; 1987 Feb; 23(2):173-81. PubMed ID: 3828194
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Therapeutic efficacy or oral pirbuterol in severe chronic congestive heart failure: acute hemodynamic and long-term ambulatory evaluation.
    Awan NA; Needham K; Evenson MK; Hermanovich J; Joye JA; DeMaria AN; Mason DT
    Am Heart J; 1981 Sep; 102(3 Pt 2):555-63. PubMed ID: 7270402
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.